Archives depression

Entry Author Date Location
PatientsLikeMe Growing as Pharma Customers Boost Focus on Patients 02/10/10 Boston
Alkermes Unveils Cheaper, Easier Technique for Making Drugs Last Longer in Blood 02/04/10 Boston
BrainCells Inc. Maps Out Next Steps for Novel Depression Drug 02/02/10 San Diego
Quanterix CEO Sets Sight on Early Detection of Cancer, Neurological Diseases in the Blood 01/19/10 Boston
Elias Zerhouni Talks Public Health Challenges, Culture Wars at WBBA Annual Meeting 11/06/09 Seattle
Orexigen Aims to Redefine Obesity, as Amgen Vet Revamps Company to Compete 09/02/09 San Diego
BrainCells Inc., Defying Convention, Suggests Novel Drug Combination Can Treat Depression 08/03/09 San Diego
BrainCells Depression Drug Reaches Goal 07/27/09 San Diego
Psylin Neurosciences—-Amylin’s Pysch-Drug Offspring—Nearing First Clinical Trial 04/27/09 San Diego
FDA Rejects Somaxon’s Application for Insomnia Drug 02/26/09 San Diego
Arena Weight Loss Drug Approaches Critical Turning Point Next Month 02/11/09 San Diego
TheraGenetics Bought by Avacta 01/29/09 Boston
Cypress Bioscience Shares Soar on News of FDA Approval 01/15/09 San Diego
Northstar Neuroscience Shuts Down, Ending Experimental Depression Trial 01/05/09 Seattle
Boston Hedge Fund Lashes Northstar Neuroscience, Urges Liquidation 12/15/08 Seattle
Brain Cells Inc., No Dummy, Raised $50M Before Recession Got Really Ugly 12/15/08 San Diego
Biotech Survival Index: Cash Running Low at Seattle Life Sciences Companies 11/13/08 Seattle
Tysabri’s Roots at the “Hutch,” MediQuest Spurned by FDA, ZymoGenetics Drug Passes Test, & More Seattle-Area Life Sciences News 11/06/08 Seattle
Northstar, Conserving Cash, Will Have $66M in Cash at Year-End 11/05/08 Seattle
Northstar Gets OK For Second Depression Study 10/14/08 Seattle
Epix CEO Resigns After Bumpy Road with Products for Depression, Alzheimer’s 07/28/08 Boston
Page 2 of 2 « previous page